Journal of Clinical Oncology

Reply to: “Is Dual-Checkpoint Blockade Beneficial Beyond Prolonging Chemoradiotherapy-to-Surgery Interval in Rectal Cancer?” and “Dual Immunotherapy in the Neoadjuvant Interval for Locally Advanced Rectal Cancer: A New Hope?”

W Wentao Tang (Department of Physics, The Hong Kong University of Science and Technology) J Jianmin Xu (Wentao Tang, MD, PhD, and Jianmin Xu, MD, PhD, Department of Colorectal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China, Shanghai Engineering Research Center of Colorectal Cancer Minimally Invasive Technology, Shanghai, China)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 24, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (2)

W

Wentao Tang

Department of Physics, The Hong Kong University of Science and Technology

J

Jianmin Xu

Wentao Tang, MD, PhD, and Jianmin Xu, MD, PhD, Department of Colorectal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China, Shanghai Engineering Research Center of Colorectal Cancer Minimally Invasive Technology, Shanghai, China

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001